bluuebunny/crossref_metadata_2025_split huggingface dataset:
Surgical approach for complete resection of giant retroperitoneal liposarcoma with diaphragmatic hernia via ninth rib thoracotomy
Authors: Hu Bai-e , Wu Chang-lei , Liu Ji-peng , Zhang Wen-jun 
Published: August 2023

BackgroundResection of a giant retroperitoneal liposarcoma is difficult and technically demanding, especially for large retroperitoneal tumors accompanied by a diaphragmatic hernia. Technically, the open abdominal approach can be time-consuming and difficult to perform, with possible intraoperative complications and other factors bringing psychological and physical difficulties to the patient. This study reports a safe and feasible approach for the complete resection of a large retroperitoneal tumor complicated by a diaphragmatic hernia.MethodsA 58-year-old male patient with persistent upper abdominal pain and distension was treated at a local hospital on 4 July 2022. Computed tomography showed a mixed-density mass on the right retroperitoneum, and liposarcoma was considered. On 6 July 2022, the patient was transferred to our hospital for further treatment. Computed tomography showed a mass with low-density fatty shadow in the right adrenal region. The boundary with the right adrenal gland was unclear. The mass was 102 mm × 74 mm, and the right lobe of the liver was compressed. Insufficiency of the right middle lobe of the liver was seen due to a right diaphragmatic hernia and left mediastinal deviation. We considered the traditional approach for tumor resection via laparotomy, but we opted to perform a comprehensive evaluation first. The tumor was close to the back of the right kidney and liver, causing the diaphragm to rise because of its proximity to these organs. Exposing the tumor through laparotomy would be difficult, making it challenging to remove. The patient had a diaphragmatic hernia and moderate pulmonary dysfunction; therefore, we decided to enter the abdomen through a thoracotomy of the ninth rib.ResultsUsing our technique, the tumor was easily visualized and completely removed in approximately 30 min. The intraoperative blood loss was 100 ml, and no postoperative bleeding, pneumothorax, intestinal fistula, infection, or other complications occurred.ConclusionThe transthoracic approach may be a safer and more feasible resection method than the traditional open approach for patients with giant retroperitoneal liposarcoma with a diaphragmatic hernia.
Closed reduction and percutaneous pinning for treatment of unstable lateral condyle fractures of the humerus in children
Authors: Qiao Fei , Guan Xiaohong , Jiang Fei , Lv Ping 
Published: August 2023

ObjectiveIn the past, obviously displaced lateral condyle fractures of the humerus in children were treated satisfactorily with open reduction and internal fixation (ORIF). However, in recent years, more studies have mentioned closed reduction and percutaneous pinning (CRPP) of these fractures.MethodsIn this retrospective investigation, the radiographic and clinical results of patients with these fractures that were initially managed with CRPP were newly classified. We classified these fractures into three groups according to the degree and pattern of fracture displacement as identified on four radiographic images. In Type I, the fracture is unstable and displacement is ≥2 mm; In Type II degree I, the fracture is unstable and displacement is &gt;2 mm, with single rotation of fragment; In Type II degree II, the fracture is unstable and displacement is &gt;2 mm, with single rotation of fragment, with rotation of fragment and antero-proximal displacement; In Type III, the fracture is unstable and displacement is &gt;2 mm, with posterior dislocation of elbow joint. We also designed an algorithm for closed reduction of these fractures according to this new classification.ResultsWe retrospectively analyzed the radiographic and clinical results of 37 unstable fractures (in 22 boys and 15 girls) that were treated with closed reduction. Twenty-one of 25 (84.0%) type I fractures, which could have been reduced to within 2 mm of residual displacement, were treated with closed reduction and pinning with 2 or 3 Kirschner wires (K wires). Three of 5 (60.0%) type II degree I, 3 of 4 (75.0%) type II degree II, and 3 of 3 (100%) type III fractures were treated with CRPP. In 4 of 25 (16.0%) type I, 2 of 5 (40.0%) type II degree I and 1 of 4 (25.0%) type II degree II fractures, closed reduction failed, so ORIF was implemented. There were no complications, such as nonunion, osteonecrosis of the capitellum, superficial or deep infection, malunion, cubitus varus or valgus, or early physeal arrest.ConclusionAlthough the management of type III fractures may not be more difficult than type II fractures with a rotated fracture fragment, as elbow dislocations are usually easy reducible. This retrospective study showed that type III fractures should not be ignored as a lateral condyle fracture that can be cured with CRPP and that lateral humeral condyle fractures with obvious displacement and rotation can be initially treated with CRPP to achieve satisfactory recovery of the elbow. Kirschner wire (K wire) fixation is recommended to avoid reoperation or anesthesia for hardware removal.
Potential analgesic effect of Foshousan oil-loaded chitosan-alginate nanoparticles on the treatment of migraine
Authors: Chen Yulong , Cheng Qingzhou , Zeng Shan , Lv Site 
Published: August 2023

Background: Migraine is a common neurovascular disorder with typical throbbing and unilateral headaches, causing a considerable healthcare burden on the global economy. This research aims to prepare chitosan-alginate (CS-AL) nanoparticles (NPs) containing Foshousan oil (FSSO) and investigate its potential therapeutic effects on the treatment of migraine.Methods: FSSO-loaded CS-AL NPs were prepared by using the single emulsion solvent evaporation method. Lipopolysaccharide (LPS)-stimulated BV-2 cells and nitroglycerin (NTG)-induced migraine mice were further used to explore anti-migraine activities and potential mechanisms of this botanical drug.Results: FSSO-loaded CS-AL NPs (212.1 ± 5.2 nm, 45.1 ± 6.2 mV) had a well-defined spherical shape with prolonged drug release and good storage within 4 weeks. FSSO and FSSO-loaded CS-AL NPs (5, 10, and 15 μg/mL) showed anti-inflammatory activities in LPS-treated BV-2 cells via reducing the levels of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and nitric oxide (NO), but elevating interleukin-10 (IL-10) expressions. Moreover, FSSO-loaded CS-AL NPs (52 and 104 mg/kg) raised pain thresholds against the hot stimulus and decreased acetic acid-induced writhing frequency and foot-licking duration in NTG-induced migraine mice. Compared with the model group, calcitonin gene-related peptide (CGRP) and NO levels were downregulated, but 5-hydroxytryptamine (5-HT) and endothelin (ET) levels were upregulated along with rebalanced ET/NO ratio, and vasomotor dysfunction was alleviated by promoting cerebral blood flow (CBF) in the FSSO-loaded CS-AL NPs (104 mg/kg) group.Conclusion: FSSO-loaded CS-AL NPs could attenuate migraine via inhibiting neuroinflammation in LPS-stimulated BV-2 cells and regulating vasoactive substances in NTG-induced migraine mice. These findings suggest that the FSS formula may be exploited as new phytotherapy for treating migraine.
The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
Authors: Wang Yanzhe , Liu Yuyuan , Chen Sijia , Li Fengqin , Wu Yue , Xie Xinmiao , Zhang Nan , Zeng Chuchu , Bai Linnan , Dai Mengshi , Zhang Ling , Wang Xiaoxia 
Published: August 2023

Background:Salvia miltiorrhiza (SM) is an effective traditional Chinese medicine for treating DKD, but the exact mechanism is elusive. In this study, we aimed to investigate and confirm the method underlying the action of the active components of SM in the treatment of DKD.Methods: Renal tissue transcriptomics and network pharmacology of DKD patients was performed to identify the active components of SM and the disease targets of DKD. Next, the point of convergence among these three groups was studied. Potential candidate genes were identified and analyzed using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG). The component-target networks were modelled and visualized with Cytoscape. In addition, docking studies were performed to validate our potential target predictions. Lastly, in vitro and in vivo experiments were performed to understand the role of Dehydromiltirone (DHT), the active component of SM, in the phenotypic switching of mesangial cells.Results: Transcriptomics of DKD patients’ renal tissues screened 4,864 differentially expressed genes. Eighty-nine active components of SM and 161 common targets were found. Functional enrichment analysis indicated that 161 genes were enriched in apoptosis, the PI3K-AKT signaling pathway, and the AGE-RAGE signaling pathway in diabetes complications. Molecular docking and molecular dynamic simulations show that DHT can bind to functional PIK3CA pockets, thereby becoming a possible inhibitor of PIK3CA. In vitro study demonstrated that DHT reduced the expression of phenotypic switching markers α-SMA, Col-I, and FN in HMCs by downregulating the over-activation of the PI3K-AKT signaling pathway through the inhibition of PIK3CA. Furthermore, the DKD mouse model confirmed that DHT could reduce proteinuria and improve glomerular hypertrophy in vivo.Conclusion: DHT was identified as the key active component of SM, and its therapeutic effect on DKD was achieved by inhibiting the phenotypic switching of mesangial cells via the PIK3CA signaling pathway.
Increase in cotton yield through improved leaf physiological functioning under the soil condition of reduced chemical fertilization compensated by the enhanced organic liquid fertilization
Authors: Shi Xiaojuan , Hao Xianzhe , Khan Aziz , Li Nannan , Li Junhong , Shi Feng , Tian Yu , Nepal Jaya , Wang Jun , Luo Honghai 
Published: August 2023

IntroductionLow agricultural nutrient input efficiency remains a significant impediment for crop production globally. To address this issue in cotton agroecosystems, there is a need to develop sustainable crop nutrient management strategies to achieve high crop yields. We hypothesized that organic liquid fertilizer (OF) combined with reduced chemical fertilizer (CF) would enhance cotton yield by improving leaf functioning and soil properties. However, the underlying mechanism and its related process is poorly understood.MethodsThis study explored the effects of OF combined with reduced CF on cotton yield, physiology and soil properties. Treatments included a single application of CF (CF: N, P2O5 and K2O applied at 228, 131 and 95 kg ha−1) and combined applications of OF and CF (OF0.6−OF1.4) in the following ratios: OF0.6, OF+60% CF; OF0.8, OF+80% CF; OF1.0, OF+100% CF; OF1.2, OF+120% CF; OF1.4, OF+140% CF. Results and discussionThe result showed that compared with CF, OF0.8, OF1.0 and OF1.2 increased soil organic matter (SOM) content by 9.9%, 16.3% and 23.7%, respectively. Compared with CF, the OF0.6, OF0.8, OF1.0, and OF1.2 treatments increased leaf area (LA) by 10.6−26.1%, chlorophyll content (Chl content) by 6.8−39.6%, and the efficiency of photosystem II (PSII) light energy (Y(II)), electron transfer rate of PSII (ETR) and photochemical quenching (qP) by 3.6−26.3%, 4.7−15.3% and 4.3−9.8%, respectively. The OF0.8 treatment increased net photosynthetic rate (Pn), stomatal conductance (Gs) and transpiration rate (E) by 22.0%, 27.4% and 26.8%, respectively, resulting in higher seed cotton yield. The seed cotton yield and economic coefficient were positively correlated with Pn, E, Gs and Y(II) from the full boll stage to the boll opening stage. In summary, the OF0.8 treatment can maintain a high SOM content and photosynthetic performance with reduced chemical fertilizer input without sacrificing yield. The integration of OF+80% CF (OF0.8) is a promising nutrient management strategy for highly efficient cotton production under mulch drip irrigation systems.
Application of improved YOLOv7-based sugarcane stem node recognition algorithm in complex environments
Authors: Wen Chunming , Guo Huanyu , Li Jianheng , Hou Bingxu , Huang Youzong , Li Kaihua , Nong Hongliang , Long Xiaozhu , Lu Yuchun 
Published: August 2023

IntroductionSugarcane stem node detection is one of the key functions of a small intelligent sugarcane harvesting robot, but the accuracy of sugarcane stem node detection is severely degraded in complex field environments when the sugarcane is in the shadow of confusing backgrounds and other objects.MethodsTo address the problem of low accuracy of sugarcane arise node detection in complex environments, this paper proposes an improved sugarcane stem node detection model based on YOLOv7. First, the SimAM (A Simple Parameter-Free Attention Module for Convolutional Neural Networks) attention mechanism is added to solve the problem of feature loss due to the loss of image global context information in the convolution process, which improves the detection accuracy of the model in the case of image blurring; Second, the Deformable convolution Network is used to replace some of the traditional convolution layers in the original YOLOv7. Finally, a new bounding box regression loss function WIoU Loss is introduced to solve the problem of unbalanced sample quality, improve the model robustness and generalization ability, and accelerate the convergence speed of the network.ResultsThe experimental results show that the mAP of the improved algorithm model is 94.53% and the F1 value is 92.41, which are 3.43% and 2.21 respectively compared with the YOLOv7 model, and compared with the mAP of the SOTA method which is 94.1%, an improvement of 0.43% is achieved, which effectively improves the detection performance of the target detection model.DiscussionThis study provides a theoretical basis and technical support for the development of a small intelligent sugarcane harvesting robot, and may also provide a reference for the detection of other types of crops in similar environments.
Fear of disease progression among breast cancer patients in China: a meta-analysis of studies using the fear of progression questionnaire short form
Authors: He Jia-Li , Xu Hui-Qiong , Yang Jing , Hou Dong-Jiang , Gong Xiao-Yan , Lu Xian-Ying , Wang Wei , Cai Ming-Jin , Yu Yu-Feng , Gao Jing 
Published: August 2023

BackgroundFear of disease progression (FoP) is among the most prevalent and major psychological burdens breast cancer patients encounter. Excessive FoP may result in serious adverse effects for patients. FoP in breast cancer patients has gained attention recently; however, its prevalence in China is unknown.ObjectivesThis meta-analysis and systematic review aimed to assess the overall FoP among Chinese breast cancer patients to make recommendations for treatment and care.MethodsSystematic search databases included PubMed, EMbase, The Cohrane Library, Web of Science, CINAHL, PsycINFO and 4 Chinese databases (Wan Fang Data, CBM, VIP and CNKI). The retrieval time ranged from the database’s establishment to March 20, 2023. After two researchers independently evaluated the literature, retrieved information, and assessed the risk of bias for the included literature, Stata 15.1 software was used to conduct a meta-analysis.ResultsA total of 37 moderate or high-quality studies involving 9,689 breast cancer patients were included. Meta-analysis showed that the pooled mean score of FoP for Chinese breast cancer patients was 33.84 [95% CI (31.91, 35.77)], prediction interval (21.57 ~ 46.11). The subgroup study found that FoP levels varied among breast cancer patients of different regions, ages, educational levels, marital statuses, residences, illness stages, and disease statuses.ConclusionBreast cancer patients have higher FoP scores. Healthcare workers should be concerned. We expect that more relevant research will be undertaken and more effective interventions will be developed. Patients can manage their illness and improve their quality of life by reducing their fears.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier: PROSPERO CRD42023408914.
Can a brief session of the online coronavirus disease 2019 destigmatization program reduce stigma among survivors? A randomized controlled trial
Authors: Techapoonpon Kamolvisa , Wonglertwisawakorn Chayut , Kerdchareon Nitchawan , Pruttithavorn Wisarat , Srikhamdokkhae Orranee 
Published: August 2023

BackgroundStigmatization has taken a heavy toll on the mental health and quality of life of the survivors of coronavirus disease 2019 (COVID-19). To address this issue, we proposed a brief, self-directed, reflective, and practical destigmatization intervention. The current study aimed to investigate the efficacy of the online COVID-19 destigmatization program (OCDP) in mitigating stigma among the survivors of COVID-19.MethodsThis study was conducted on 142 survivors of COVID-19 before their discharge from Vajra Hospital from July 2022 to November 2022. The participants were randomly assigned between the intervention group (n = 71), who attended the 40-min OCDP, and the control group (n = 71), who received standard mental health care. The primary outcome was the efficacy of OCDP in reducing stigmatization. A COVID-19 stigma questionnaire was administered to assess stigmatization in the intervention and control groups immediately before and after the program during follow-up on days 7, 14, and 28. The secondary outcome was the efficacy of the program in alleviating negative emotions according to the Depression Anxiety Stress Scale 21 questionnaire.ResultsCompared with the control group, the intervention group had a more prominent reduction in the overall stigma score on day 7 (p = 0.002) and day 14 (p = 0.028). The intervention group had a more evident reduction in enacted stigma (day 7, p = 0.04), internalized stigma (day 7, p = 0.008; day 14, p &lt; 0.028), and perceived external stigma (day 7, p = 0.002) than the control group. However, there was no significant difference in terms of disclosure concern between the intervention and control groups. Furthermore, the reduction in depression, anxiety, and stress between the two groups did not significantly differ.ConclusionOnline COVID-19 destigmatization program provided prior to hospital discharge is an effective tool in reducing stigmatization, particularly within the first 2 weeks after reintegration into society, among the survivors of COVID-19.
Evaluation of thrombin generation in dogs administered clopidogrel
Authors: Rank Kaitlyn , Lynch Alex M. , Ruterbories Laura K. , Li Ronald H. L. , Ueda Yu 
Published: August 2023

IntroductionThe antiplatelet effect of clopidogrel can vary between patients. A modified thromboelastography (TEG) protocol (TEG-Platelet Mapping assay® [TEG-PM]) can be used for clopidogrel monitoring but is not widely available. Thrombin generation (TG) assays could offer a novel alternative. The main objective of this pilot study was to assess TG assay variables (lag time, peak, endogenous thrombin potential [ETP]) in dogs before and after 7 days of clopidogrel administration and compare with TEG-PM variables (maximum amplitude [MA]-ADP and percentage (%) inhibition).MethodsSix healthy mix-breed dogs were enrolled in this pilot study. Blood samples for platelet count, TG assays, and TEG-PM were obtained at two time points, corresponding to baseline, and after 7 days of clopidogrel administration (mean 2.3 +/− 0.3 mg/kg PO q24 hours). Data were then compared with a Student’s t-test.ResultsThere was no significant change in TG assay variables performed on platelet poor plasma after 7 days of clopidogrel administration: lag time (Day 1: 1.8 +/− 0.2 min, Day 7: 1.8 +/− 0.2 min, p = 0.42); peak (Day 1: 76 +/− 7 nM, Day 7: 72 +/− 10 nM, p = 0.49); and ETP (Day 1: 399 +/− 27 nM*min, Day 7: 392 +/− 32 nM*min; p = 0.49). There were significant changes in TEG MA-ADP (Day 1: 19 +/− 8 mm, Day 7: 9 +/− 6 mm, p = 0.04) and % inhibition (Day 1: 58 +/− 27, Day 7: 99 +/− 0.3, p = 0.02).DiscussionClopidogrel administration did not lead to changes in TG assay variables performed on platelet poor plasma samples, despite concomitant changes in TEG-PM variables consistent with platelet inhibition. Based on this pilot study, thrombin generation performed on platelet poor plasma may not be a useful antiplatelet monitoring tool in dogs.
Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis
Authors: Shilo-Benjamini Yael , Lavy Eran , Yair Nadav , Milgram Joshua , Zilbersheid Daniel , Hod Atara , Barasch Dinorah , Abu Ahmad Wiessam , Cern Ahuva , Barenholz Yechezkel 
Published: August 2023

IntroductionOsteoarthritis is a common disease in dogs resulting in chronic pain and decreased wellbeing. Common analgesics such as non-steroidal anti-inflammatories may fail to control pain and can produce major adverse effects. Study objectives were to evaluate pharmacokinetics, therapeutic efficacy, and safety of subcutaneous liposomal-cannabidiol (CBD) as an additional analgesic therapy in dogs suffering from naturally-occurring osteoarthritis.MethodsSix such dogs were recruited following ethics approval and owner consent. Dogs were administered a single subcutaneous injection of 5 mg/kg liposomal-CBD. Plasma concentrations of CBD, blood work, activity monitoring collar data, wellbeing questionnaire (owners) and pain scoring (veterinarian) were performed at baseline and monitored up to six weeks following intervention. Data overtime were compared with baseline using linear-regression mixed-effects. P-value was set at 0.05.ResultsCBD plasma concentrations were observed for 6 weeks; median (range) peak plasma concentration (Cmax) was 45.2 (17.8–72.5) ng/mL, time to Cmax was 4 (2–14) days and half-life was 12.4 (7.7–42.6) days. Median (range) collar activity score was significantly increased on weeks 5–6; from 29 (17–34) to 34 (21–38). Scores of wellbeing and pain evaluations were significantly improved at 2–3 weeks; from 69 (52–78) to 53.5 (41–68), and from 7.5 (6–8) to 5.5 (5–7), respectively. The main adverse effect was minor local swelling for several days in 5/6 dogs.ConclusionLiposomal-CBD administered subcutaneously produced detectable CBD plasma concentrations for 6 weeks with minimal side effects and demonstrated reduced pain and increased wellbeing as part of multimodal pain management in dogs suffering from osteoarthritis. Further placebo-controlled studies are of interest.